<html>
<head>
<title>Section 318:51-f Licensure of Research Organizations.</title>
<!-- Hide metadata
<titlename>TITLE XXX OCCUPATIONS AND PROFESSIONS</titlename>
<chapter>CHAPTER 318 PHARMACISTS AND PHARMACIES</chapter>
<sectiontitle>Section 318:51-f Licensure of Research Organizations.</sectiontitle>
-->
</head>
<body>
<center><h1>TITLE XXX<br>OCCUPATIONS AND PROFESSIONS</h1></center>
<center><h2>CHAPTER 318<br>PHARMACISTS AND PHARMACIES</h2></center>
<center><h2>Possession and Sale of Drugs and Devices for Administration of Drugs</h2></center>
<center><h3>Section 318:51-f</h3></center>
&nbsp;&nbsp;&nbsp;<b> 318:51-f Licensure of Research Organizations. &#150;</b>
<codesect>
<br>
&nbsp&nbsp&nbsp
I. No research organization shall procure or conduct research operations with prescription drugs by researchers without first having obtained a license from the board.  Such license shall expire annually on June 30.  An application together with a reasonable fee as established by the board shall be filed annually on or before July 1.
<br>
&nbsp&nbsp&nbsp
II. No license shall be issued under this section unless the applicant has furnished proof satisfactory to the board of pharmacy:
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(a) That the applicant is of good moral character or, if that applicant is an association or corporation, that the managing officers are of good moral character.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(b) That the applicant has sufficient space and security equipment as to properly carry on the research operations described in the application.
<br>
&nbsp&nbsp&nbsp
III. The license granted under this section shall at all times be displayed in a conspicuous place in the research organization facility for which it is issued.
<br>
&nbsp&nbsp&nbsp
IV. No license shall be issued under this section to research organizations for sale, dispensing, or distribution of prescription drugs.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(a) Prescription drugs are to be used solely for research purposes only.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(b) Use of controlled drugs is prohibited under the license for research organizations issued under this section.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(c) No research organization shall distribute prescription drugs directly to a consumer or a patient, or operate in such a manner as to endanger the public health.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(d) The research organization shall effectively destroy all prescription drugs in due course by means of conducting routine research operations or disposal by approved methods.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(e) The research organization shall maintain up-to-date and accurate records indicating:
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(1) The amount of prescription drug destroyed.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(2) The date on which the prescription drug was destroyed.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(3) The manner or method by which the prescription drug was destroyed.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(f) Inventories and disposal transactions shall be maintained for 2 years and made available for inspection by the board's inspectors within a period of 72 hours from notice.
<br>
&nbsp&nbsp&nbsp
V. No license shall be granted to any research organization if any of its managing officers or researchers have within 5 years been convicted of a violation of any law of the United States, or of any state, relating to drugs, as defined by this chapter or RSA 318-B, or is an impaired person.
<br>
&nbsp&nbsp&nbsp
VI. Any licensee under this section is subject to the provisions of RSA 318:29.
<br>
&nbsp&nbsp&nbsp
VII. (a) The licensee shall, within 30 days of any change of information supplied in the original license application, notify the board.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(b) The notice required pursuant to subparagraph (a) shall contain the:
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(1) Current New Hampshire license number of the research organization.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(2) Name of managing officers and researchers, old and new, if applicable.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(3) Address of the research organization, old and new, if applicable.
<br>
&nbsp&nbsp&nbsp
VIII. A new license shall be required for a change of ownership of an established research organization to a successor business entity which results in a change in the controlling interest in the research organization.
</codesect>
<sourcenote>
<p><b>Source.</b>  2015, 203:5, eff. July 1, 2015.</p>
</sourcenote>
</body>
</html>
